Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on February 22, 2025

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

Motley Fool

a day ago

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

GILD or VRTX: Which Is the Better Value Stock Right Now?

Zacks

2 days ago

GILD or VRTX: Which Is the Better Value Stock Right Now?

MT Newswires

2 days ago

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $408 From $407, Maintains Sector Perform Rating

Vertex to Participate in Upcoming March Investor Conferences

Business Wire

3 days ago

Vertex to Participate in Upcoming March Investor Conferences

3 Stocks That Could Trounce the Market in 2025

Motley Fool

5 days ago

3 Stocks That Could Trounce the Market in 2025

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

Motley Fool

7 days ago

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

8 days ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

8 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

The Ultimate Healthcare Stock to Buy With $500 Right Now

Motley Fool

8 days ago

The Ultimate Healthcare Stock to Buy With $500 Right Now

Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing

Motley Fool

8 days ago

Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing

MT Newswires

9 days ago

Vertex Pharmaceuticals Insider Sold Shares Worth $632,726, According to a Recent SEC Filing

Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank

TipRanks

10 days ago

Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank

Vertex Pharmaceuticals price target raised to $520 from $460 at Truist

TipRanks

10 days ago

Vertex Pharmaceuticals price target raised to $520 from $460 at Truist

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks

10 days ago

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

MT Newswires

10 days ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $500 From $501, Maintains Overweight Rating

MT Newswires

10 days ago

Redburn Atlantic Adjusts Price Target on Vertex Pharmaceuticals to $560 From $550, Maintains Buy Rating

MT Newswires

10 days ago

Daiwa Adjusts Price Target on Vertex Pharmaceuticals to $530 From $550, Maintains Buy Rating

MT Newswires

10 days ago

Canaccord Genuity Upgrades Vertex Pharmaceuticals to Hold From Sell, Adjusts Price Target to $424 From $408

Morningstar Research

10 days ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.

Investor's Business Daily

10 days ago

Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.

Vertex: Strong Sales, Stronger Pipeline

Motley Fool

11 days ago

Vertex: Strong Sales, Stronger Pipeline

Thomson Reuters StreetEvents

11 days ago

Q4 2024 Vertex Pharmaceuticals Inc Earnings Call

MT Newswires

11 days ago

RBC Raises Price Target on Vertex Pharmaceuticals to $407 From $402, Keeps Sector Perform Rating

MT Newswires

11 days ago

Scotiabank Adjusts Price Target on Vertex Pharmaceuticals to $450 From $433, Maintains Sector Perform Rating

MT Newswires

11 days ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $459 From $450, Maintains Equalweight Rating

MT Newswires

11 days ago

Truist Adjusts Price Target on Vertex Pharmaceuticals to $520 From $460, Maintains Buy Rating

MT Newswires

11 days ago

Leerink Partners Adjusts Price Target on Vertex Pharmaceuticals to $550 From $542, Maintains Outperform Rating

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 50% Above Its Share Price

Simply Wall St.

12 days ago

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Intrinsic Value Is Potentially 50% Above Its Share Price

Argus Research

12 days ago

Weekly Stock List

2 Biotech Stocks to Buy Hand Over Fist in February

Motley Fool

13 days ago

2 Biotech Stocks to Buy Hand Over Fist in February

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

StockStory

13 days ago

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

What To Expect in the Markets This Week

Investopedia

13 days ago

What To Expect in the Markets This Week

MT Newswires

15 days ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $501 From $500

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Zacks

16 days ago

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?

Zacks

17 days ago

Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?

Unlocking Q4 Potential of Vertex (VRTX): Exploring Wall Street Estimates for Key Metrics

Zacks

17 days ago

Unlocking Q4 Potential of Vertex (VRTX): Exploring Wall Street Estimates for Key Metrics

Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks

18 days ago

Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?

Motley Fool

18 days ago

Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?

US Stocks Estimated To Be Trading Below Intrinsic Value In February 2025

Simply Wall St.

18 days ago

US Stocks Estimated To Be Trading Below Intrinsic Value In February 2025

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Zacks

18 days ago

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

3 Magnificent Stocks to Buy and Hold Forever

Motley Fool

19 days ago

3 Magnificent Stocks to Buy and Hold Forever

Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?

Zacks

19 days ago

Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

19 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

Zacks

19 days ago

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?

Motley Fool

20 days ago

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?

Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?

Motley Fool

20 days ago

Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?

Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank

TipRanks

21 days ago

Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank

These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More

Barrons.com

21 days ago

These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More

How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter

Investor's Business Daily

21 days ago

How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter

AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute

Yahoo Finance Video

22 days ago

AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute

Vertex stock jumps on FDA approval of new non-opioid painkiller

Yahoo Finance Video

22 days ago

Vertex stock jumps on FDA approval of new non-opioid painkiller

No Major Catalyst, Wells Fargo Downgraded Vertex

GuruFocus.com

22 days ago

No Major Catalyst, Wells Fargo Downgraded Vertex

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Barrons.com

22 days ago

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up

Zacks

22 days ago

VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up

Vertex Pharmaceuticals (NASDAQ:VRTX) lifts 3.2% this week, taking five-year gains to 83%

Simply Wall St.

23 days ago

Vertex Pharmaceuticals (NASDAQ:VRTX) lifts 3.2% this week, taking five-year gains to 83%

MT Newswires

23 days ago

Wells Fargo Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Price Target is $460

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

24 days ago

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

25 days ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Earnings Preview: Vertex Pharmaceuticals (VRTX) Q4 Earnings Expected to Decline

Zacks

a month ago

Earnings Preview: Vertex Pharmaceuticals (VRTX) Q4 Earnings Expected to Decline

MT Newswires

a month ago

Morgan Stanley Adjusts Vertex Pharmaceuticals Price Target to $450 From $456, Maintains Equal Weight Rating

Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10

Business Wire

a month ago

Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $591 From $602, Keeps Buy Rating

MT Newswires

a month ago

Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $533 From $535, Maintains Overweight Rating

Is Vertex Pharmaceuticals Stock a Buy in 2025?

Motley Fool

a month ago

Is Vertex Pharmaceuticals Stock a Buy in 2025?

Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.

Motley Fool

a month ago

Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

a month ago

Exploring Three High Growth Tech Stocks In The United States

2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher

Motley Fool

a month ago

2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher

Vertex Down 13% in 6 Months: Buy, Sell or Hold the Stock?

Zacks

a month ago

Vertex Down 13% in 6 Months: Buy, Sell or Hold the Stock?

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

MT Newswires

a month ago

RBC Adjusts Price Target on Vertex Pharmaceuticals to $402 From $401, Maintains Sector Perform Rating

Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever

Motley Fool

a month ago

Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever

3 Unstoppable Stocks to Buy in 2025

Motley Fool

a month ago

3 Unstoppable Stocks to Buy in 2025

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?

Motley Fool

a month ago

Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?

Morningstar Research

a month ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Zacks

a month ago

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

Benzinga

a month ago

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

My 3 Highest-Conviction Growth Stocks to Buy in 2025

Motley Fool

a month ago

My 3 Highest-Conviction Growth Stocks to Buy in 2025

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Business Wire

a month ago

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement

TipRanks

a month ago

Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement

Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know

MT Newswires

a month ago

Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $460 From $555, Maintains Overweight Rating

INCY vs. VRTX: Which Stock Is the Better Value Option?

Zacks

a month ago

INCY vs. VRTX: Which Stock Is the Better Value Option?

Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials

Insider Monkey

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials

MT Newswires

a month ago

Vertex, Zai Lab Partner Over Povetacicept Development in China, 4 Other Regions

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Business Wire

a month ago

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Business Wire

a month ago

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

MT Newswires

a month ago

Morgan Stanley Lowers Price Target on Vertex Pharmaceuticals to $456 From $476, Keeps Equalweight Rating

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 42% Undervalued

Simply Wall St.

a month ago

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 42% Undervalued

Vertex and Orna sign partnership to improve efficiencies of gene therapies

Pharmaceutical Technology

a month ago

Vertex and Orna sign partnership to improve efficiencies of gene therapies

MT Newswires

a month ago

Vertex, Orna Therapeutics Collaborate on Gene Editing Therapies for Sickle Cell Disease, Beta Thalassemia

MT Newswires

a month ago

RBC Lifts Price Target on Vertex Pharmaceuticals to $401 From $400, Keeps Sector Perform Rating

Vertex, startup Orna to partner on gene editing research

BioPharma Dive

a month ago

Vertex, startup Orna to partner on gene editing research

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

PR Newswire

a month ago

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

3 US Stocks Estimated To Be Undervalued By Up To 42%

Simply Wall St.

2 months ago

3 US Stocks Estimated To Be Undervalued By Up To 42%

Jim Cramer’s Take on Vertex Pharmaceuticals (VRTX): Bold Predictions for the Future

Insider Monkey

2 months ago

Jim Cramer’s Take on Vertex Pharmaceuticals (VRTX): Bold Predictions for the Future

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) three years ago are up 79%

Simply Wall St.

2 months ago

Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) three years ago are up 79%

Share on Social Networks: